Intelligence Β· Clinical Pipeline

Prime Medicine Pipeline

All ClinicalTrials.gov programs at Prime Medicine β€” phase, modality, and trial IDs.

Programs
5

Quick answer

Prime Medicine has 5 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Bemarituzumab

    Prime Medicine

    Gastric Cancer

    phase 2 mab completed

    1 trial
  2. FP-1039

    Prime Medicine

    Endometrial Cancers With FGFR2 Mutations

    phase 2 small molecule terminated

    1 trial
  3. FPA008

    Prime Medicine

    Pigmented Villonodular Synovitis

    phase 2 mab completed

    1 trial
  4. PM359

    Prime Medicine

    Chronic Granulomatous Disease

    phase 2 mab active

    1 trial
  5. Pumecitinib Nasal Spray 0.3%

    Prime Medicine

    Seasonal Allergic Rhinitis

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many pipeline programs does Prime Medicine have?

5 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources Β· All pipeline programs